Ergomed (ERGO)

 

ERGO Share PerformanceMore

52 week high172.00 08/01/16
52 week low117.00 16/09/16
52 week change -21.00 (-12.54%)
4 week volume283,353 13/11/16

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Ergomed CFO and general counsel granted options

Ergomed founder and chief executive Dr Miroslav Reljanovic has granted options over 100,000 ordinary shares from his p...

Award of Options by CEO to CFO and General Counsel

Acquisition of PharmInvent

Statement regarding an acquisition of a company or assets

Ergomed chairman to step down

Ergomed chairman Rolf Stahel will retire from the board at the end of his three year term of office on 31 March and wil...

Proposed Board Changes

Notification of any change to a company’s board e.g. appointments/resignations/changes to important functions or executive responsibilities of a director

Ergomed expands clinical study with Modus Therapeutics

Ergomed has noted that its co-development partner Modus Therapeutics Holding AB has announced that following a plan...

Research Update from Modus Therapeutics

Holding(s) in Company

Notification of major interests in shares

Fundamental DataMore

P/E ratio27.13
EPS5.4
Dividend yield0 %

Equity Research (ERGO)

equity development
Ergomed Plc
11/10/2016
Ergomed offers clinical trial and pharmacovigilance services to pharmaceutical companies, while also co-developing a product portfolio of therapies. It has unusually high revenue visibility, indeed...

Latest discussion posts More

  • Webinar with management

    We will be hosting a webinar with the management of Ergomed tomorrow (Tuesday 27th September) at 11.15. There will be a presentation of the interim results lasting around ...
    26-Sep-2016
    equity_dev

Users' HoldingsMore

Users who hold Ergomed also hold..
SOMERO ENTER DI28%
COHORT28%
GVC HLDGS28%
NEW CITY ENERGY28%
TRITAX BIG BOX28%

Codes & Symbols

ISINGB00BN7ZCY67
SymbolsERGO, LSE:ERGO, ERGO.L, ERGO:LN, LON:ERGO, XLON:ERGO